Physician

Bassam Haddad, MD

According to 2025 Medicare claims, Bassam Haddad, MD (NPI: 1871741967) practices rheumatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is PREMIER PHYSICIANS CENTERS, INC. (NPI: 1780634279; TIN: 341783789) and primary practice location at 44145-4146. Haddad is affiliated with the Aledade 157 OH MSSP Enhanced (ACO ID: A5360), participating under the MSSP model.

Haddad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 395 traditional Medicare patients, billed 73,974 HCPCS/CPT codes, and received $737,820 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,528 prescription claims across 797 beneficiaries totaling $7,424,505 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 256 records totaling $20,571. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $78,484 to $737,820. Similarly, Part D prescription costs have moved sharply higher in recent years, from $138,397 to $7,424,505. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	314	1,937	$78,484
2016	530	4,534	$152,397
2017	528	9,604	$313,766
2018	471	10,778	$359,802
2019	443	18,573	$415,073
2020	406	40,870	$710,863
2021	424	35,816	$661,342
2022	412	52,205	$592,520
2023	425	67,632	$764,758
2024	395	73,974	$737,820

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	148	512	$138,397
2016	325	1,150	$260,512
2017	571	4,105	$1,313,655
2018	650	5,456	$2,206,229
2019	733	6,591	$3,030,773
2020	730	7,050	$3,400,116
2021	748	7,164	$5,165,022
2022	771	7,379	$6,055,440
2023	787	7,380	$6,589,438
2024	797	7,528	$7,424,505

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	234	410	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	136	208	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	130	174	$12
80053	Blood test, comprehensive group of blood chemicals	125	194	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	123	190	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	172	5,348	$1,351,731
Rinvoq	Upadacitinib	159	5,310	$1,165,809
Taltz Autoinjector	Ixekizumab	110	3,248	$832,553
Cosentyx Sensoready Pen	Secukinumab	76	2,128	$588,483
Enbrel Sureclick	Etanercept	55	1,540	$405,995

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	256	$20,571	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bassam Haddad, MD?

Tedicare shows public-source Medicare data for Bassam Haddad, MD (NPI 1871741967), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bassam Haddad, MD have ACO affiliation data?

Bassam Haddad, MD is shown with ACO affiliation data for Aledade 157 OH MSSP Enhanced (MSSP, ACO ID A5360).

What billing organization is linked to Bassam Haddad, MD?

Bassam Haddad, MD is linked to PREMIER PHYSICIANS CENTERS, INC. (billing NPI 1780634279) in the available physician profile data.

Does Bassam Haddad, MD have Open Payments data?

Bassam Haddad, MD has 256 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.